WALD Stock Forecast & Price Target

Waldencast PLC demonstrated a solid financial performance with a year-over-year sales increase of 5.6% in the second quarter, achieving total sales of $66.8 million. The company's growth trajectory accelerated in the third quarter, reporting a 10.1% increase, driven primarily by eCommerce and international expansion within both the Milk Makeup and Obagi segments. Notably, Milk Makeup outperformed the broader prestige beauty market, with year-to-date consumption growth of 12%, which is four times the market's growth rate, contributing to a positive outlook for Waldencast's stock.

Waldencast PLC has revised its fiscal year 2025 outlook downward, projecting flat revenue and an adjusted EBITDA margin in the high single digits, reflecting broader operational challenges. The company experienced a significant contraction in consolidated adjusted gross margin by 310 basis points year-over-year, driven by declines in both its Obagi and Milk Makeup segments, with the latter reporting a steep 20% year-over-year sales decrease. Additionally, the overall sales performance fell short of expectations, culminating in a total revenue decline of 3.4% year-over-year, raising concerns about the sustainability of growth in the company's key brands.